Drug for celiac disease shows promise in treating severe post-COVID syndrome in children

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.
👉 Full Story

United Health Group Stock Drops 50% and Moody’s Lowers US Credit Rating
- ChatGPT just got smarter: OpenAI’s Study Mode helps students learn step-by-step - Michael Nuñez
- Adapting to Market Changes: The Bitcoin Ordinals Gaming Project Bits - Christian J. Cunningham
- Flickering lights could help fight misinformation - Andre Revilla
- Exploring the New Generative AI Features in Google Chrome - Sean George
- The Spectacle Ep. 253: Zeldin and Trump Are Setting Us Free From the EPA - Melissa Mackenzie
- Google's New Machine Learning Algorithm is A Weapon Against Fake Reviews - Michael A. Medeiros

Hangry Karen pulls gun at McDonald’s, demands Egg McMuffin
- Signs and Symptoms of Inflammatory Bowel Disease (IBD) - Lindsay Curtis
- Deepfake Voices: A New Challenge for Detection Technologies - Michael Terry
- How to Make $1500 in a Month Without a Car - Zoul
- The Wishlist for the Next Big Monster Hunter Game - Michael A. Medeiros
- BBC’s Laura Kuenssberg stunned as Reform share plans for legal cases against government - Isaiah Amos
- Google confirms it will sign the EU AI Code of Practice - Ryan Whitwam